124 related articles for article (PubMed ID: 16932728)
1. Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
Holers VM
Nat Clin Pract Rheumatol; 2006 Aug; 2(8):400-1. PubMed ID: 16932728
[No Abstract] [Full Text] [Related]
2. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
Ménard HA
J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
[No Abstract] [Full Text] [Related]
3. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
4. Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents.
Russell AS; Maksymowych WP; de Silva M
Ann Rheum Dis; 2005 Dec; 64(12):1807. PubMed ID: 16284357
[No Abstract] [Full Text] [Related]
5. Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis.
Rodríguez-Mahou M; López-Longo FJ; Sánchez-Ramón S; Estecha A; García-Segovia A; Rodríguez-Molina JJ; Carreño L; Fernández-Cruz E
Arthritis Rheum; 2006 Aug; 55(4):657-61. PubMed ID: 16874789
[No Abstract] [Full Text] [Related]
6. Anti-cyclic citrullinated peptide antibody versus HAQ/MDHAQ: comparing apples and oranges?
Bykerk V
J Rheumatol; 2009 Aug; 36(8):1565-7. PubMed ID: 19671806
[No Abstract] [Full Text] [Related]
7. Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis.
Jansen TL; Bruyn GA
J Rheumatol; 2004 May; 31(5):1012-3; author reply 1013. PubMed ID: 15124273
[No Abstract] [Full Text] [Related]
8. Antibodies to citrullinated proteins in arthritis: pathology and promise.
Klareskog L; Widhe M; Hermansson M; Rönnelid J
Curr Opin Rheumatol; 2008 May; 20(3):300-5. PubMed ID: 18388522
[TBL] [Abstract][Full Text] [Related]
9. Duration of pre-rheumatoid arthritis anti-cyclic citrullinated peptide positivity is positively associated with age at seroconversion.
Bos WH; Nielen MM; Dijkmans BA; van Schaardenburg D
Ann Rheum Dis; 2008 Nov; 67(11):1642. PubMed ID: 18854513
[No Abstract] [Full Text] [Related]
10. Anti-cyclic citrullinated peptide antibody determination in the synovial fluid of patients with rheumatoid arthritis: comment on the article by Caspi et al.
Spadaro A; Riccieri V; Scrivo R; Alessandri C; Valesini G
Arthritis Rheum; 2006 Aug; 55(4):681-2; author reply 682. PubMed ID: 16874773
[No Abstract] [Full Text] [Related]
11. Clinical significance of anti-citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis.
Nakamura H; Kawakami A; Ida H; Origuchi T; Matsuoka N; Tsuboi M; Furuyama M; Mizokami A; Tsukada T; Nakashima M; Ejima E; Hamasaki K; Aoyagi K; Uetani M; Fukuda T; Honda S; Urayama S; Kawabe Y; Ueki Y; Mine M; Eguchi K
Scand J Rheumatol; 2005; 34(6):489-90. PubMed ID: 16393775
[No Abstract] [Full Text] [Related]
12. Diagnostic value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
Mofidi M; Moghadam A
Saudi Med J; 2008 Aug; 29(8):1206-7. PubMed ID: 18690324
[No Abstract] [Full Text] [Related]
13. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
14. Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome.
Cavagna L; Fusetti C; Montecucco C; Caporali R
J Rheumatol; 2010 Sep; 37(9):1967; author reply 1968. PubMed ID: 20810525
[No Abstract] [Full Text] [Related]
15. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP
Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267
[TBL] [Abstract][Full Text] [Related]
16. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
Jansen TL
Ned Tijdschr Geneeskd; 2003 Apr; 147(15):729-30; author reply 730-1. PubMed ID: 12722537
[No Abstract] [Full Text] [Related]
17. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
Lee AN; Beck CE; Hall M
Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
